Add BrightSurf on Google Email

Diabetologia


Small study suggests twice-daily aspirin dosing could lead to more cardiovascular benefits for people with type 2 diabetes

A new study presents evidence that taking aspirin twice daily could provide more cardiovascular benefits for individuals with type 2 diabetes. The research found that platelet aggregation increased over the standard 24-hour dosing interval when aspirin was only taken once daily, suggesting a need for antiplatelet treatment that covers ...

Large studies find screening reduces mortality for those with detectable type 2 diabetes but not for general population

Three large trials found that screening for type 2 diabetes and cardiovascular risk factors does not reduce mortality in the general population, but individuals diagnosed with diabetes experience reduced mortality rates. The studies suggest that benefits to the general population may be increased by targeting screening to those at grea...

SourceDiabetologia·JournalDiabetologia·DateAug 23, 2017

New study reveals the association between type 2 diabetes and the risk of death from cancer in East and South Asians

A new study published in Diabetologia found that having type 2 diabetes increases the risk of death from any form of cancer by 26%, even when controlling for other factors. The research also revealed statistically significant links between T2D and specific cancers, including liver, pancreas, breast, kidney, and endometrium.

SourceDiabetologia·JournalDiabetologia·DateMar 7, 2017

Study of over 700,000 births shows increased risk of poor outcomes, including death, for babies born to mothers with gestational diabetes

A new study published in Diabetologia found that babies born to mothers with gestational diabetes have a higher risk of preterm birth, Caesarean section, and cardiac malformations. The study also revealed an increased risk of death for newborns born to mothers with insulin-treated gestational diabetes.

SourceDiabetologia·JournalDiabetologia·DateFeb 15, 2017

Higher iron levels are associated with an increased risk of gestational diabetes in pregnant women, raising questions about iron supplementation recommendations

A study published in Diabetologia found that high iron biomarkers are linked to an increased risk of gestational diabetes in pregnant women. Higher iron stores may play a role in developing insulin resistance and oxidative stress, contributing to impaired insulin synthesis and secretion.

SourceDiabetologia·JournalDiabetologia·DateNov 10, 2016

Artificial pancreas likely to be available by 2018

The artificial pancreas, a device monitoring blood glucose levels and automatically adjusting insulin doses, is nearing availability. Clinical trials have shown effective glucose control with reduced risk of hypoglycaemia, but challenges remain in addressing speed of action and cybersecurity concerns.

SourceDiabetologia·JournalDiabetologia·DateJun 30, 2016

New link found between diabetes and Alzheimer's disease

Research reveals a close relationship between Alzheimer's disease and type 2 diabetes, with drugs used to treat diabetes potentially alleviating Alzheimer's symptoms and vice versa. The study found that dementia-related complications can lead to changes in glucose handling and ultimately diabetes.

SourceDiabetologia·JournalDiabetologia·DateJun 21, 2016

Study finds targeting 'ideal cardiovascular health' lowers diabetes risk, but with ethnic differences

A new study published in Diabetologia shows that significant racial/ethnic differences exist in the association between ideal cardiovascular health and diabetes risk. Achieving four or more of the American Heart Association's ideal cardiovascular health components resulted in lower rates of incident diabetes, with 34% and 75% reduction...

SourceDiabetologia·JournalDiabetologia·DateJun 8, 2016

Study reveals substantial reductions in years lived without disability and overall life expectancy for men and women with diabetes

Research published in Diabetologia found that people with diabetes face reduced overall life expectancy and higher numbers of years living with disability compared to those without diabetes. The study estimated a loss of 3-9 years of life expectancy and 8-9 years of disability-free life expectancy for men and women with diabetes.

SourceDiabetologia·JournalDiabetologia·DateApr 14, 2016